Eisai US Tech Stack

Oncology and neurology pharma with U.S. commercial and research operations

Pharmaceutical Manufacturing Nutley, NJ 1,001–5,000 employees Founded 1995 Public Company

Eisai U.S. is a fully integrated pharmaceutical subsidiary focused on oncology and neurology, with discovery labs in Massachusetts and Pennsylvania, clinical development in New Jersey, and supply-chain operations across Maryland and North Carolina. The hiring mix skews heavily toward sales (36 roles) and healthcare professionals (23), reflecting a commercial-stage business navigating product launches and reimbursement barriers—not a discovery or manufacturing-driven organization.

Tech Stack 16 technologies

Core StackWorkday Zscaler AWS CloudWatch PowerPoint PDF HPLC LC-MS qPCR SDS-PAGE Informatica IDMC BIRT Zscaler Private Access ThousandEyes SolarWinds Veeva

What Eisai US Is Building

◆Challenges

Launching new product
Educating hcps
Patient access to prescribed products
Reimbursement issues
Patient access challenges
Regulatory risk mitigation
Compliant execution of access and reimbursement programs
Reimbursement challenges
Gap on unmet educational needs
Securing product access through p&t coordination

▲Active Projects

Access and reimbursement education for eisai alzheimer’s product
New product launch
Territory business strategy development
Pull-through sales within integrated delivery networks
Training programs for sales force
Training tool development
National hsae engagement strategy
Brand plans
Strategies for access and reimbursement across region
Strategy development for access and reimbursement

Hiring Activity

Steady85 roles · 35 in 30d

Department

Sales

Healthcare

Research

Legal

Manufacturing

Marketing

Ops

Data

Seniority

Senior

Director

Mid

Manager

Lead

Notable leadership hires: Associate Director, Medical Director, Network Lead, Training Lead, Sales Director

Company intelligence

Find more companies like Eisai US by tech stack, pain points and active projects

Get started free

About Eisai US

Eisai Inc. U.S. operates as a fully integrated pharmaceutical company developing and marketing therapies in oncology (metastatic breast cancer, renal cell carcinoma, hepatocellular carcinoma) and neurology (Alzheimer's disease, dementia-related and neurodegenerative diseases, epilepsy, insomnia). As the U.S. subsidiary of Tokyo-based Eisai Co., Ltd., the company maintains discovery labs in Massachusetts and Pennsylvania, commercial and clinical development headquarters in New Jersey, and demand-chain operations in Maryland and North Carolina. Current organizational activity centers on new product launches, sales-force training, healthcare provider education, and navigating reimbursement and patient-access challenges across hospital networks and pharmacy-and-therapeutics committees.

HeadquartersNutley, NJ

Company Size1,001–5,000 employees

Founded1995

Hiring MarketsUnited States

Frequently Asked Questions

What tech does Eisai use?

Eisai's stack emphasizes lab and clinical infrastructure (HPLC, LC-MS, qPCR, SDS-PAGE), enterprise data and HR (Informatica IDMC, Workday, Veeva), and cloud/security (AWS, Zscaler, CloudWatch). No recent adopting or replacing signals in the data.

Where is Eisai U.S. headquartered?

Eisai Inc. U.S. headquarters is in Nutley, New Jersey. The company also operates discovery labs in Massachusetts and Pennsylvania, and supply-chain operations in Maryland and North Carolina.